Homoeopathic Medicines Bryonia alba 30C as a Prophylaxis for COVID-19
Phase 4
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B338- Other specified viral diseases
- Registration Number
- CTRI/2020/06/025558
- Lead Sponsor
- Principal Aarogya Homoeopathic Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Persons in Quarantine centres with history of exposure, with all the following shall be included:
1.Suspected cases of COVID-19 who are asymptomatic.
2.Age 18 years and above and all genders
3.Willing to give written informed consent.
Exclusion Criteria
1.Pregnant women or lactating mothers
2.Immunocompromised individuals on basis of medical history
3.Symptomatic (similar to COVID-19) cases at quarantine facility.
4.Rapidly progressive respiratory failure and sepsis.
5.Aged below 18 yrs
6.Not willing to give informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The results of the study will be able to determine the prophylactic effect of Homoeopathic Medicines in COVId-19 cases. If found effective, this could prove to be a Vital contribution in public health care for this Global Crisis of COVID-19.Timepoint: 1 week
- Secondary Outcome Measures
Name Time Method Further, the cost-effectiveness of Homeopathy will enable developing countries in controlling such deadly disease effectively.Timepoint: 6 months